Clinical Trial

Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered Cellgram-CKD in PMC-P-12 Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This long-term follow-up study is a 5-year long-term follow-up study to evaluate long-term safety in Cellgram-CKD subjects. (refer to ClinicalTrials.gov.Identifier: NCT05042206).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-10-15.
Status change: Not Yet Recruiting → Active, Not Recruiting 2024-03-21
Trial Details
NCT Number NCT05096182
Lead Sponsor Pharmicell Co., Ltd.
Conditions Renal Insufficiency, Chronic
Enrollment 10 participants
Start Date 2022-03-10
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2024-03-25